During the past decade, Isipingo CRS conducted 6 clinical trials. In the 10-year time frame, 6 clinical trials started and 3 clinical trials were completed, i.e. on average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 3 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Isipingo CRS" #1 collaborator was "National Institute of Allergy and Infectious Diseases (NIAID)" with 4 trials as a collaborator, "Bill and Melinda Gates Foundation" with 2 trials as a collaborator, "GlaxoSmithKline" with 2 trials as a collaborator, "Department of Health and Human Services" with 1 trials as a collaborator and "Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)" with 1 trials as a collaborator. Other collaborators include 2 different institutions and companies that were collaborators in the rest 12 trials.

According to Clinical.Site data, the most researched conditions in "Isipingo CRS" are "HIV Infections" (4 trials), "COVID-19" (2 trials), "SARS-CoV-2" (2 trials) and "HIV Infection" (1 trials). Many other conditions were trialed in "Isipingo CRS" in a lesser frequency.

Most popular intervention types in "Isipingo CRS" are "Biological" (3 trials), "Other" (2 trials) and "Drug" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (2 trials), "Sample collection" (2 trials), "ALVAC-HIV" (1 trials), "ALVAC-HIV (vCP2438)" (1 trials) and "ALVAC-HIV (vCP2438) Placebo" (1 trials). Other intervention names were less common.

The vast majority of trials in "Isipingo CRS" are 5 trials for "All" genders and 2 trials for "Female" genders.

Currently, there are NaN active trials in "Isipingo CRS". undefined are not yet recruiting, undefined are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 5 completed trials in Isipingo CRS, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Isipingo CRS, 2 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".